All individuals with BOS have clinically identified ASXL1 mutations in the last 2 exons of the gene that are predicted to cause protein-truncating variants (NM_015338.6) between amino acids 364 and 1415 (Figure 1A and Supplemental Table 1). Here, ASXL1 is linked to Buschke-Ollendorff syndrome.